Work

What Patients are Reading About Prenatal Cell‐Free DNA: An Analysis of Leading Publicly Available AI‐Chatbots

Year: 2026
Type: article
Abstract: OBJECTIVE: To characterize the quality, consistency, and framing of information about prenatal cell-free DNA (cfDNA) screening generated by publicly available chatbots, including variation across simulated user age profiles. METHODS: We conducted a qualitative content analysis of outputs from three publicly available chatbots. To reduce carryover effects and personalization, prompts were entered using a VPN, private browsing, and cleared browser cookies. Outputs were generated using distinct simulated user age profiles. Analysis examined informational completeness, framing of benefits and limitations, terminology, source transparency, and age-related differences in responses. RESULTS: Chatbot outputs varied substantially across platforms and user profiles, with misinformation, omissions, and incomplete information identified. Common themes included inconsistent explanations of the purpose and scope of cfDNA screening, frequent omission of test limitations and downstream implications, and variable readability scores (at a 9th-14th grade level) and terminology that sometimes conflate screening with diagnostic testing. Citations to high-quality sources were limited or absent. Age-based profile variation was associated with differences in tone, complexity, and emphasis, suggesting implicit tailoring of information presentation. CONCLUSION: Publicly available chatbots may provide inaccurate or inconsistent information about cfDNA screening. As these tools are increasingly used outside clinical settings, improving accuracy, transparency, discussion of limitations, and source citation is essential to support reliable patient-facing health information.
Language: English
Field: Medicine
Open Access status: hybrid
Estimated APC paid: $4,640
OpenAlex ID: W7226498074
FWCI:
Cites: 27
Cited by:
Related to: 10